PREVIEW: Kimberly-Clark dips; results due Tues before the bell
** Kimberly-Clark KMB.N shares were down 0.5% in afternoon trading on Mon ahead of the company's quarterly results due before the opening bell on Tues, with investors expecting a decline in revenue
** Co is expected to report a dip in rev to $5.05 bln from $5.13 bln a yr ago, while it is expected to report EPS of $1.70 vs $1.74 in the yr ago period, according to LSEG data
** The co has beaten analysts' earnings expectations in six of the last eight reporting periods, based on LSEG data
** Analyst recommendations include seven "strong buy" or "buy" ratings, 11 "hold" ratings and two "sell" or "strong sell" ratings, per LSEG
** The median 12-mo price target is $152.50; the stock was last at $144.73
** In July, Kimberly-Clark raised its forecast for full-year profit, betting on higher prices and steady demand for its personal care products
** On Sept. 30, Bloomberg News reported, citing people familiar with the matter, that Kimberly-Clark is exploring the sale of its international tissue business
** Including the session move, the stock is up 19% for the YTD vs a roughly 23% gain in the S&P 500 .SPX
Reporting by Caroline Valetkevitch
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
